Mediaspace scheduled maintenance: Aug 25, 2026 07:00 - 12:00 AM. During this time, videos will be temporarily unavailable. Check status updates.

Person

Carlos Canto Alvarez

Teaching & PhD PhD Students Laurine Cécile Florentine Van Gijn, Marie Denise Rumpler Past EPFL PhD Students Joanna Ratajczak, Miriam Valera Alberni, Angélique Satoko Cercillieux Courses Sustainable Food: production, health & society HUM-120(b) The course offers an overview of issues linked to nutrition: sustainable production, food security, food safety, as well as food and health. The interdisciplinary approach integrates SHS with engineering sciences and introduces students to team work and to scientific methodology.

Official source

https://people.epfl.ch/carles.canto?lang=en

About this result

This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.

Official source

https://people.epfl.ch/carles.canto?lang=en

About this result

Related units (1)

Prof. Deplancke Group

Courses taught by this person (1)

HUM-120(b): Sustainable Food: production, health & society

Le cours présente les enjeux liés à l'alimentation: production durable, sécurité alimentaire, sécurité sanitaire et liens entre alimentation et santé. L'approche interdisciplinaire intègre les SHS et les sciences de l'ingénieur et initie au travail de grou ...

Related publications (47)

Please note that this is not a complete list of this person’s publications. It includes only semantically relevant works. For a full list, please refer to Infoscience.

People doing similar research (1)

Johan Auwerx

Johan Auwerx is Professor at the École Polytechnique Fédérale in Lausanne, Switzerland, where he occupies the Nestle Chair in Energy Metabolism. Dr. Auwerx has been using molecular physiology and systems genetics to understand metabolism in health, aging and disease. Much of his work focused on understanding how diet, exercise and hormones control metabolism through changing the expression of genes by altering the activity of transcription factors and their associated cofactors. His work was instrumental for the development of agonists of nuclear receptors - a particular class of transcription factors - into drugs, which now are used to treat high blood lipid levels, fatty liver, and type 2 diabetes. Dr. Auwerx was amongst the first to recognize that transcriptional cofactors, which fine-tune the activity of transcription factors, act as energy sensors/effectors that influence metabolic homeostasis. His research validated these cofactors as novel targets to treat metabolic diseases, and spurred the clinical use of natural compounds, such as resveratrol, as modulators of these cofactor pathways. Johan Auwerx was elected as a member of EMBO in 2003 and is the recipient of a dozen of international scientific prizes, including the Danone International Nutrition Award, the Oskar Minkowski Prize, and the Morgagni Gold Medal. His work is highly cited by his peers with a h-factor of over 100. He is an editorial board member of several journals, including Cell Metabolism, Molecular Systems Biology, The EMBO Journal, Journal of Cell Biology, Cell, and Science. Dr. Auwerx co-founded a handful of biotech companies, including Carex, PhytoDia, and most recently Mitobridge, and has served on several scientific advisory boards. Dr. Auwerx received both his MD and PhD in Molecular Endocrinology at the Katholieke Universiteit in Leuven, Belgium. He was a post-doctoral research fellow in the Departments of Medicine and Genetics of the University of Washington in Seattle.

People doing similar research (1)

Johan Auwerx

Carlos Canto Alvarez

Graph Chatbot

PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure

NAD(+) repletion improves muscle function in muscular dystrophy and counters global PARylation

Trigonelline is an NAD+ precursor that improves muscle function during ageing and is reduced in human sarcopenia